Capricor Therapeutics (CAPR) Non-Current Assets (2010 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Non-Current Assets of $43.2 million for Q1 2026, up 474.78% year-over-year from $7.5 million in Q1 2025, and up 30.86% quarter-over-quarter from $33.0 million in Q4 2025.
Capricor Therapeutics (CAPR) Non-Current Assets (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Non-Current Assets history runs 17 years deep, the most recent figure standing at $43.2 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 474.78% year-over-year to $43.2 million; the TTM figure through Mar 2026 stood at $111.1 million (up 278.68% YoY), while the FY2025 annual figure was $33.0 million, up 365.2% from the prior year.
- Non-Current Assets for Q1 2026 stood at $43.2 million, up from $33.0 million in the prior quarter.
- The five-year high for Non-Current Assets was $43.2 million in Q1 2026, with the low at $5.3 million in Q1 2022.
- The 5-year median for Non-Current Assets is $7.5 million (2025), against an average of $11.9 million.
- The sharpest annual moves came in 2024 and 2026: Non-Current Assets slipped 9.94% in 2024, then jumped 474.78% in 2026.
- Capricor Therapeutics' Non-Current Assets stood at $7.2 million in 2022, then gained by 9.33% to $7.9 million in 2023, then fell by 9.94% to $7.1 million in 2024, then jumped by 365.2% to $33.0 million in 2025, then soared by 30.86% to $43.2 million in 2026.
- Business Quant data shows CAPR's Non-Current Assets at $43.2 million in Q1 2026, $33.0 million in Q4 2025, and $25.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 294.93 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.96 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 18.06 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 938.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - | 43.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.19 Mn |
| Dec 31, 2025 | 33.01 Mn |
| Sep 30, 2025 | 25.49 Mn |
| Jun 30, 2025 | 9.44 Mn |
| Mar 31, 2025 | 7.51 Mn |
| Dec 31, 2024 | 7.10 Mn |
| Sep 30, 2024 | 7.13 Mn |
| Jun 30, 2024 | 7.61 Mn |
| Mar 31, 2024 | 8.03 Mn |
| Dec 31, 2023 | 7.88 Mn |
| Sep 30, 2023 | 7.62 Mn |
| Jun 30, 2023 | 7.09 Mn |
| Mar 31, 2023 | 7.27 Mn |
| Dec 31, 2022 | 7.21 Mn |
| Sep 30, 2022 | 6.42 Mn |
| Jun 30, 2022 | 5.44 Mn |
| Mar 31, 2022 | 5.29 Mn |
| Dec 31, 2021 | 4.89 Mn |
| Sep 30, 2021 | 1.80 Mn |
| Jun 30, 2021 | 1.20 Mn |